Neumarker Inc.

📍 Palo Alto, United States🗓 Founded 2022👥 7 employees💰 Last funded May 2021
Mental Health Care🌐 neumarker.ai
Website LinkedIn
CNS disorders are often treated ineffectively by trial-and-error, causing prolonged patient distress and high healthcare costs. Neumarker aims to transform the treatment of CNS disorders through its cutting-edge brain biomarker discovery platform, powered by AI. By identifying predictive brain biomarkers, we can personalize treatment for each patient and accelerate drug development by efficient clinical trials. Neumarker is committed to advancing precision neuromedicine through collaborations with drug developers, clinicians and academic researchers.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Neumarker Inc.?
Neumarker Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Neumarker Inc. last raise funding?
The most recent investment in Neumarker Inc. recorded on gritt.io was in May 2021.
When was Neumarker Inc. founded?
Neumarker Inc. was founded in 2022.
What industry is Neumarker Inc. in?
Neumarker Inc. operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Neumarker Inc. based?
Neumarker Inc. is headquartered in Palo Alto, United States.